Continued low rates of HCV recurrence in HCV/HIV and HCV infected participants who achieved SVR after DAA treatment: Final results from the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
Keyword(s):
Abstract Final results from the long-term VHICS cohort found low rates of HCV recurrence after DAA therapy in both HCV/HIV (0.67/100 p-y) and HCV (0.2/100 p-y) groups with over 500 person years of follow-up. Confirmed re-infections were in participants with HIV who reported high-risk behaviors.